Skip to content

Pathology of Hepatitis c Nephropathy

Different Histopathological Patterns in Patients With HCV Nephropathy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03476031
Enrollment
50
Registered
2018-03-23
Start date
2018-11-30
Completion date
2019-12-31
Last updated
2018-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cryoglobulinaemia Due to Chronic Hepatitis C

Brief summary

Hepatitis c associated glomerulonephritis is an immune complex disease that occurs in 21% of patients who have HCV infection.

Detailed description

Hepatitis C virus infection is a major public health problem with an estimated global prevalence of 3% and an estimated 5-20% of infected patients will develop liver cirrhosis .The Prevalence of Hepatitis C infection in end stage renal disease is greater than in the general population especially in those on hemodialysis which reflects nosocomial transmission of the disease in the hemodialysis environment. Hepatitis C associated glomerulonephritis is an immune complex disease that occurs in 21% of patients who have HCV infection. It most commonly presents as membranoproliferative and mixed cryoglobulinemia It characterized by an indolent course in one third of patients , remission in another third and relapsing course in the remaining patients with potential progression to advanced chronic kidney disease. mechanism of injury : Chronic Hepatitis C is primarily associated with type II cryoglobulinemia , in which the primary mechanism of injury is vasculitis that occurs via immune complex deposition. hepatitis C virus related glomerular disease : Type I membranoproliferative was the most common finding associated with mixed cryoglobulinemia but other forms of glomerulonephritis were associated with Hepatitis c like mesangial glomerulonephritis,focal and segmental glomerulonephritis,minimal change nephropathy,membranous nephropathy , Fibrillary glomerulonephritis,immunotactoid glomerulopathy,IgA nephropathy, vasculitic renal involvement ,poly arteritis nodosa and interstitial nephritis .

Interventions

DIAGNOSTIC_TESTrenal biopsy

needle biopsy will be taken from the kidney tissue then, diagnosed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* it will be conducted on chronic hepatitis C patients with chronic kidney disease . * The participants will be classified according to their estimated GFR by modified MDRD equation and * they will be recruited from the renal unit of internal medicine, Assiut University Hospitals and assiut hepatitis viruses unit-ministry of health, Egypt.

Exclusion criteria

Patients will be excluded if the underlying causes of CRF are as follows: chronic pyelonephritis,obstructive uropathy,Polycystic kidney disease,Patients with ESRD on regular hemodialysis,patients with advanced liver cirrhosis,hepatocellular carcinoma,Patients on steroids or immunosuppressive drugs and Solitary kidney.

Design outcomes

Primary

MeasureTime frameDescription
prevalence of histopathological pattern in patients with hepatitis C virusone yearprevalence of histopathological pattern in patients with hepatitis C virus

Countries

Egypt

Contacts

Primary ContactMohammad Tohamy, MD
proftohammy@yahoo.com00201227270775
Backup ContactEffat Tony, MD
Effattoni@gmail.com00201097330309

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026